申请人:Paratek Pharmaceuticals, Inc.
公开号:EP2949644A2
公开(公告)日:2015-12-02
The present invention pertains, at least in part, to novel substituted tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for tetracycline compounds such as blocking tetracycline efflux and modulation of gene expression.
本发明至少部分涉及新型取代
四环素化合物。这些
四环素化合物可用于治疗多种
四环素化合物反应状态,如细菌感染和肿瘤,以及
四环素化合物的其他已知应用,如阻断
四环素外流和调节
基因表达。